[PHARMA] QoQ TTM Result on 31-Dec-2001 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Feb-2002
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2001
Quarter
31-Dec-2001 [#4]
Profit Trend
QoQ- 27.94%
YoY- 24.18%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Revenue 594,966 578,889 553,176 543,496 503,335 480,247 461,639 18.41%
PBT 64,797 58,312 52,093 51,604 44,517 41,544 41,349 34.87%
Tax -26,084 -24,033 -22,413 -20,800 -20,440 -17,894 -15,934 38.85%
NP 38,713 34,279 29,680 30,804 24,077 23,650 25,415 32.35%
-
NP to SH 38,713 34,279 29,680 30,804 24,077 23,650 25,415 32.35%
-
Tax Rate 40.25% 41.21% 43.02% 40.31% 45.92% 43.07% 38.54% -
Total Cost 556,253 544,610 523,496 512,692 479,258 456,597 436,224 17.57%
-
Net Worth 172,829 159,457 167,817 160,519 151,781 143,956 140,265 14.91%
Dividend
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Div 5,002 3,750 3,750 3,750 2,509 2,509 2,509 58.33%
Div Payout % 12.92% 10.94% 12.64% 12.18% 10.42% 10.61% 9.87% -
Equity
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Net Worth 172,829 159,457 167,817 160,519 151,781 143,956 140,265 14.91%
NOSH 50,095 49,986 49,945 50,006 49,928 49,984 50,094 0.00%
Ratio Analysis
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
NP Margin 6.51% 5.92% 5.37% 5.67% 4.78% 4.92% 5.51% -
ROE 22.40% 21.50% 17.69% 19.19% 15.86% 16.43% 18.12% -
Per Share
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
RPS 1,187.67 1,158.09 1,107.56 1,086.86 1,008.12 960.79 921.53 18.41%
EPS 77.28 68.58 59.42 61.60 48.22 47.31 50.73 32.36%
DPS 10.00 7.50 7.50 7.50 5.00 5.00 5.00 58.67%
NAPS 3.45 3.19 3.36 3.21 3.04 2.88 2.80 14.91%
Adjusted Per Share Value based on latest NOSH - 50,006
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
RPS 41.28 40.17 38.38 37.71 34.92 33.32 32.03 18.40%
EPS 2.69 2.38 2.06 2.14 1.67 1.64 1.76 32.65%
DPS 0.35 0.26 0.26 0.26 0.17 0.17 0.17 61.76%
NAPS 0.1199 0.1106 0.1164 0.1114 0.1053 0.0999 0.0973 14.92%
Price Multiplier on Financial Quarter End Date
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Date 30/09/02 28/06/02 29/03/02 31/12/01 27/09/01 29/06/01 30/03/01 -
Price 7.68 7.32 7.32 7.27 5.73 6.36 6.82 -
P/RPS 0.65 0.63 0.66 0.67 0.57 0.66 0.74 -8.27%
P/EPS 9.94 10.67 12.32 11.80 11.88 13.44 13.44 -18.20%
EY 10.06 9.37 8.12 8.47 8.42 7.44 7.44 22.25%
DY 1.30 1.02 1.02 1.03 0.87 0.79 0.73 46.86%
P/NAPS 2.23 2.29 2.18 2.26 1.88 2.21 2.44 -5.81%
Price Multiplier on Announcement Date
30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 CAGR
Date 22/11/02 26/08/02 21/05/02 20/02/02 26/11/01 29/08/01 24/05/01 -
Price 7.36 7.86 7.86 6.77 6.82 6.82 6.77 -
P/RPS 0.62 0.68 0.71 0.62 0.68 0.71 0.73 -10.30%
P/EPS 9.52 11.46 13.23 10.99 14.14 14.41 13.34 -20.12%
EY 10.50 8.72 7.56 9.10 7.07 6.94 7.49 25.23%
DY 1.36 0.95 0.95 1.11 0.73 0.73 0.74 49.98%
P/NAPS 2.13 2.46 2.34 2.11 2.24 2.37 2.42 -8.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment